APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide CRO Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peptide CRO Services Industry Growth and Trends Forecast to 2032

23 December 2025123 pages

Choose your research edition.

Industry ResearchPeptide CRO Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide CRO Services Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Peptide CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide CRO Services Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide CRO Services Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

According to APO Research, the global Peptide CRO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Peptide CRO Services market include IMED Bioscience, Peptites Biotech, Genevoyager, Viva Biotech, Space Peptides Pharmaceutical, Motif Biotechnology, JYMed Technology, GenScript and TriApex Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peptide CRO Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peptide CRO Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide CRO Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide CRO Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Peptide CRO Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peptide CRO Services Market by Company

IMED Bioscience

Peptites Biotech

Genevoyager

Viva Biotech

Space Peptides Pharmaceutical

Motif Biotechnology

JYMed Technology

GenScript

TriApex Laboratories

Go Top Peptide Biotech

Sun-Novo Pharmaceutical Research

Thermo Fisher

Syngene

Svar Life Science

PolyPeptide

PeptiSystems

Peptide Institute

Immunocure

Cusabio

CSBio

CPC Scientific

Buchi

Bachem AG

Aurigene Pharmaceutical Services

AmbioPharm

ABZENA PLC

Peptide CRO Services Segment by Type

Modified Peptide Synthesis

Linear Peptide Synthesis

Cyclic Peptide Synthesis

Others

Peptide CRO Services Segment by Application

Pharmaceutical Companies

Biological Laboratories

Others

Peptide CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Peptide CRO Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Peptide CRO Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Peptide CRO Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Peptide CRO Services Market Share by Region (2021-2026) Table 4. Global Peptide CRO Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Peptide CRO Services Market Share by Region (2027-2032) Table 6. Global Peptide CRO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Peptide CRO Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Peptide CRO Services Market Size Share by Type (2021-2026) Table 9. Global Peptide CRO Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Peptide CRO Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Peptide CRO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Peptide CRO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Peptide CRO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Peptide CRO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Peptide CRO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Peptide CRO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Peptide CRO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Peptide CRO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Peptide CRO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Peptide CRO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Peptide CRO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Peptide CRO Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Peptide CRO Services Market Size Share by Application (2021-2026) Table 24. Global Peptide CRO Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Peptide CRO Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Peptide CRO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Peptide CRO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Peptide CRO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Peptide CRO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Peptide CRO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Peptide CRO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Peptide CRO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Peptide CRO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Peptide CRO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Peptide CRO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Peptide CRO Services Industry Trends Table 37. Peptide CRO Services Industry Drivers Table 38. Peptide CRO Services Industry Opportunities and Challenges Table 39. Peptide CRO Services Industry Restraints Table 40. Global Peptide CRO Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Peptide CRO Services Revenue Market Share by Company (2021-2026) Table 42. Global Peptide CRO Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Peptide CRO Services Key Company Headquarters & Area Served Table 44. Global Peptide CRO Services Company, Product Type & Application Table 45. Global Peptide CRO Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Peptide CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. IMED Bioscience Company Information Table 49. IMED Bioscience Business Overview Table 50. IMED Bioscience Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. IMED Bioscience Peptide CRO Services Product Portfolio Table 52. IMED Bioscience Recent Development Table 53. Peptites Biotech Company Information Table 54. Peptites Biotech Business Overview Table 55. Peptites Biotech Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Peptites Biotech Peptide CRO Services Product Portfolio Table 57. Peptites Biotech Recent Development Table 58. Genevoyager Company Information Table 59. Genevoyager Business Overview Table 60. Genevoyager Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Genevoyager Peptide CRO Services Product Portfolio Table 62. Genevoyager Recent Development Table 63. Viva Biotech Company Information Table 64. Viva Biotech Business Overview Table 65. Viva Biotech Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Viva Biotech Peptide CRO Services Product Portfolio Table 67. Viva Biotech Recent Development Table 68. Space Peptides Pharmaceutical Company Information Table 69. Space Peptides Pharmaceutical Business Overview Table 70. Space Peptides Pharmaceutical Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio Table 72. Space Peptides Pharmaceutical Recent Development Table 73. Motif Biotechnology Company Information Table 74. Motif Biotechnology Business Overview Table 75. Motif Biotechnology Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Motif Biotechnology Peptide CRO Services Product Portfolio Table 77. Motif Biotechnology Recent Development Table 78. JYMed Technology Company Information Table 79. JYMed Technology Business Overview Table 80. JYMed Technology Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. JYMed Technology Peptide CRO Services Product Portfolio Table 82. JYMed Technology Recent Development Table 83. GenScript Company Information Table 84. GenScript Business Overview Table 85. GenScript Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GenScript Peptide CRO Services Product Portfolio Table 87. GenScript Recent Development Table 88. TriApex Laboratories Company Information Table 89. TriApex Laboratories Business Overview Table 90. TriApex Laboratories Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. TriApex Laboratories Peptide CRO Services Product Portfolio Table 92. TriApex Laboratories Recent Development Table 93. Go Top Peptide Biotech Company Information Table 94. Go Top Peptide Biotech Business Overview Table 95. Go Top Peptide Biotech Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Go Top Peptide Biotech Peptide CRO Services Product Portfolio Table 97. Go Top Peptide Biotech Recent Development Table 98. Sun-Novo Pharmaceutical Research Company Information Table 99. Sun-Novo Pharmaceutical Research Business Overview Table 100. Sun-Novo Pharmaceutical Research Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio Table 102. Sun-Novo Pharmaceutical Research Recent Development Table 103. Thermo Fisher Company Information Table 104. Thermo Fisher Business Overview Table 105. Thermo Fisher Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Thermo Fisher Peptide CRO Services Product Portfolio Table 107. Thermo Fisher Recent Development Table 108. Syngene Company Information Table 109. Syngene Business Overview Table 110. Syngene Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Syngene Peptide CRO Services Product Portfolio Table 112. Syngene Recent Development Table 113. Svar Life Science Company Information Table 114. Svar Life Science Business Overview Table 115. Svar Life Science Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Svar Life Science Peptide CRO Services Product Portfolio Table 117. Svar Life Science Recent Development Table 118. PolyPeptide Company Information Table 119. PolyPeptide Business Overview Table 120. PolyPeptide Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. PolyPeptide Peptide CRO Services Product Portfolio Table 122. PolyPeptide Recent Development Table 123. PeptiSystems Company Information Table 124. PeptiSystems Business Overview Table 125. PeptiSystems Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. PeptiSystems Peptide CRO Services Product Portfolio Table 127. PeptiSystems Recent Development Table 128. Peptide Institute Company Information Table 129. Peptide Institute Business Overview Table 130. Peptide Institute Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Peptide Institute Peptide CRO Services Product Portfolio Table 132. Peptide Institute Recent Development Table 133. Immunocure Company Information Table 134. Immunocure Business Overview Table 135. Immunocure Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Immunocure Peptide CRO Services Product Portfolio Table 137. Immunocure Recent Development Table 138. Cusabio Company Information Table 139. Cusabio Business Overview Table 140. Cusabio Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Cusabio Peptide CRO Services Product Portfolio Table 142. Cusabio Recent Development Table 143. CSBio Company Information Table 144. CSBio Business Overview Table 145. CSBio Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. CSBio Peptide CRO Services Product Portfolio Table 147. CSBio Recent Development Table 148. CPC Scientific Company Information Table 149. CPC Scientific Business Overview Table 150. CPC Scientific Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. CPC Scientific Peptide CRO Services Product Portfolio Table 152. CPC Scientific Recent Development Table 153. Buchi Company Information Table 154. Buchi Business Overview Table 155. Buchi Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Buchi Peptide CRO Services Product Portfolio Table 157. Buchi Recent Development Table 158. Bachem AG Company Information Table 159. Bachem AG Business Overview Table 160. Bachem AG Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Bachem AG Peptide CRO Services Product Portfolio Table 162. Bachem AG Recent Development Table 163. Aurigene Pharmaceutical Services Company Information Table 164. Aurigene Pharmaceutical Services Business Overview Table 165. Aurigene Pharmaceutical Services Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio Table 167. Aurigene Pharmaceutical Services Recent Development Table 168. AmbioPharm Company Information Table 169. AmbioPharm Business Overview Table 170. AmbioPharm Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. AmbioPharm Peptide CRO Services Product Portfolio Table 172. AmbioPharm Recent Development Table 173. ABZENA PLC Company Information Table 174. ABZENA PLC Business Overview Table 175. ABZENA PLC Peptide CRO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. ABZENA PLC Peptide CRO Services Product Portfolio Table 177. ABZENA PLC Recent Development Table 178. North America Peptide CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. North America Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million) Table 180. North America Peptide CRO Services Market Share by Country (2021-2026) Table 181. North America Peptide CRO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. North America Peptide CRO Services Market Share Forecast by Country (2027-2032) Table 183. Europe Peptide CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Europe Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million) Table 185. Europe Peptide CRO Services Market Share by Country (2021-2026) Table 186. Europe Peptide CRO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Europe Peptide CRO Services Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Peptide CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Peptide CRO Services Market Share by Country (2021-2026) Table 191. Asia-Pacific Peptide CRO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Peptide CRO Services Market Share Forecast by Country (2027-2032) Table 193. Latin America Peptide CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Peptide CRO Services Market Share by Country (2021-2026) Table 196. Latin America Peptide CRO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Peptide CRO Services Market Share Forecast by Country (2027-2032) Table 198. Middle East & Africa Peptide CRO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East & Africa Peptide CRO Services Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East & Africa Peptide CRO Services Market Share by Country (2021-2026) Table 201. Middle East & Africa Peptide CRO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East & Africa Peptide CRO Services Market Share Forecast by Country (2027-2032) Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Peptide CRO Services Product Image Figure 3. Global Peptide CRO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Peptide CRO Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Peptide CRO Services Market Share by Region: 2025 VS 2032 Figure 6. Global Peptide CRO Services Market Share by Region (2021-2032) Figure 7. North America Peptide CRO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Peptide CRO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Peptide CRO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Peptide CRO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Peptide CRO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Modified Peptide Synthesis Image Figure 13. Global Modified Peptide Synthesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Linear Peptide Synthesis Image Figure 15. Global Linear Peptide Synthesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Cyclic Peptide Synthesis Image Figure 17. Global Cyclic Peptide Synthesis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Peptide CRO Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Peptide CRO Services Market Share by Type 2025 VS 2032 Figure 22. North America Peptide CRO Services Market Size Share by Type (2021-2032) Figure 23. Europe Peptide CRO Services Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Peptide CRO Services Market Size Share by Type (2021-2032) Figure 25. Latin America Peptide CRO Services Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Peptide CRO Services Market Size Share by Type (2021-2032) Figure 27. Pharmaceutical Companies Image Figure 28. Global Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biological Laboratories Image Figure 30. Global Biological Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Peptide CRO Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Peptide CRO Services Market Share by Application 2025 VS 2032 Figure 35. North America Peptide CRO Services Market Size Share by Application (2021-2032) Figure 36. Europe Peptide CRO Services Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Peptide CRO Services Market Size Share by Application (2021-2032) Figure 38. Latin America Peptide CRO Services Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Peptide CRO Services Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Peptide CRO Services Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Peptide CRO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Peptide CRO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Peptide CRO Services Market Share by Country (2021-2032) Figure 45. Europe Peptide CRO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Peptide CRO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peptide CRO Services Market Share by Country (2021-2032) Figure 48. Asia-Pacific Peptide CRO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Peptide CRO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Peptide CRO Services Market Share by Country (2021-2032) Figure 51. Latin America Peptide CRO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Peptide CRO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peptide CRO Services Market Share by Country (2021-2032) Figure 54. Middle East & Africa Peptide CRO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Peptide CRO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Peptide CRO Services Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Modified Peptide Synthesis
  • Linear Peptide Synthesis
  • Cyclic Peptide Synthesis
  • Others
Applications
  • Pharmaceutical Companies
  • Biological Laboratories
  • Others
Companies covered
  • IMED Bioscience
  • Peptites Biotech
  • Genevoyager
  • Viva Biotech
  • Space Peptides Pharmaceutical
  • Motif Biotechnology
  • JYMed Technology
  • GenScript
  • TriApex Laboratories
  • Go Top Peptide Biotech
  • Sun-Novo Pharmaceutical Research
  • Thermo Fisher
  • Syngene
  • Svar Life Science
  • PolyPeptide
  • PeptiSystems
  • Peptide Institute
  • Immunocure
  • Cusabio
  • CSBio
  • CPC Scientific
  • Buchi
  • Bachem AG
  • Aurigene Pharmaceutical Services
  • AmbioPharm
  • ABZENA PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Peptide CRO Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Peptide CRO Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Peptide CRO Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Peptide CRO Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Peptide CRO Services Market Size (2021-2032)
  8. 1.5.1 North America Peptide CRO Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Peptide CRO Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Peptide CRO Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Peptide CRO Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Peptide CRO Services Market Size Growth Rate (2021-2032)
2 Peptide CRO Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Modified Peptide Synthesis
  3. 2.1.2 Linear Peptide Synthesis
  4. 2.1.3 Cyclic Peptide Synthesis
  5. 2.1.4 Others
  6. 2.2 Global Peptide CRO Services Market Size by Type
  7. 2.2.1 Global Peptide CRO Services Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Peptide CRO Services Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Peptide CRO Services Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Peptide CRO Services Market Size by Regions
  11. 2.3.1 North America Peptide CRO Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Peptide CRO Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Peptide CRO Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Peptide CRO Services Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Peptide CRO Services Market Size Breakdown by Type (2021-2026)
3 Peptide CRO Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Companies
  3. 3.1.2 Biological Laboratories
  4. 3.1.3 Others
  5. 3.2 Global Peptide CRO Services Market Size by Application
  6. 3.2.1 Global Peptide CRO Services Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Peptide CRO Services Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Peptide CRO Services Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Peptide CRO Services Market Size by Regions
  10. 3.3.1 North America Peptide CRO Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Peptide CRO Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Peptide CRO Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Peptide CRO Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Peptide CRO Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Peptide CRO Services Industry Trends
  2. 4.2 Peptide CRO Services Industry Drivers
  3. 4.3 Peptide CRO Services Industry Opportunities and Challenges
  4. 4.4 Peptide CRO Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Peptide CRO Services Revenue (2021-2026)
  2. 5.2 Global Peptide CRO Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Peptide CRO Services Key Company Headquarters & Area Served
  4. 5.4 Global Peptide CRO Services Company, Product Type & Application
  5. 5.5 Global Peptide CRO Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Peptide CRO Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Peptide CRO Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Peptide CRO Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 IMED Bioscience
  2. 6.1.1 IMED Bioscience Company Information
  3. 6.1.2 IMED Bioscience Business Overview
  4. 6.1.3 IMED Bioscience Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 IMED Bioscience Peptide CRO Services Product Portfolio
  6. 6.1.5 IMED Bioscience Recent Developments
  7. 6.2 Peptites Biotech
  8. 6.2.1 Peptites Biotech Company Information
  9. 6.2.2 Peptites Biotech Business Overview
  10. 6.2.3 Peptites Biotech Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Peptites Biotech Peptide CRO Services Product Portfolio
  12. 6.2.5 Peptites Biotech Recent Developments
  13. 6.3 Genevoyager
  14. 6.3.1 Genevoyager Company Information
  15. 6.3.2 Genevoyager Business Overview
  16. 6.3.3 Genevoyager Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Genevoyager Peptide CRO Services Product Portfolio
  18. 6.3.5 Genevoyager Recent Developments
  19. 6.4 Viva Biotech
  20. 6.4.1 Viva Biotech Company Information
  21. 6.4.2 Viva Biotech Business Overview
  22. 6.4.3 Viva Biotech Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Viva Biotech Peptide CRO Services Product Portfolio
  24. 6.4.5 Viva Biotech Recent Developments
  25. 6.5 Space Peptides Pharmaceutical
  26. 6.5.1 Space Peptides Pharmaceutical Company Information
  27. 6.5.2 Space Peptides Pharmaceutical Business Overview
  28. 6.5.3 Space Peptides Pharmaceutical Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Space Peptides Pharmaceutical Peptide CRO Services Product Portfolio
  30. 6.5.5 Space Peptides Pharmaceutical Recent Developments
  31. 6.6 Motif Biotechnology
  32. 6.6.1 Motif Biotechnology Company Information
  33. 6.6.2 Motif Biotechnology Business Overview
  34. 6.6.3 Motif Biotechnology Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Motif Biotechnology Peptide CRO Services Product Portfolio
  36. 6.6.5 Motif Biotechnology Recent Developments
  37. 6.7 JYMed Technology
  38. 6.7.1 JYMed Technology Company Information
  39. 6.7.2 JYMed Technology Business Overview
  40. 6.7.3 JYMed Technology Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 JYMed Technology Peptide CRO Services Product Portfolio
  42. 6.7.5 JYMed Technology Recent Developments
  43. 6.8 GenScript
  44. 6.8.1 GenScript Company Information
  45. 6.8.2 GenScript Business Overview
  46. 6.8.3 GenScript Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GenScript Peptide CRO Services Product Portfolio
  48. 6.8.5 GenScript Recent Developments
  49. 6.9 TriApex Laboratories
  50. 6.9.1 TriApex Laboratories Company Information
  51. 6.9.2 TriApex Laboratories Business Overview
  52. 6.9.3 TriApex Laboratories Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 TriApex Laboratories Peptide CRO Services Product Portfolio
  54. 6.9.5 TriApex Laboratories Recent Developments
  55. 6.10 Go Top Peptide Biotech
  56. 6.10.1 Go Top Peptide Biotech Company Information
  57. 6.10.2 Go Top Peptide Biotech Business Overview
  58. 6.10.3 Go Top Peptide Biotech Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Go Top Peptide Biotech Peptide CRO Services Product Portfolio
  60. 6.10.5 Go Top Peptide Biotech Recent Developments
  61. 6.11 Sun-Novo Pharmaceutical Research
  62. 6.11.1 Sun-Novo Pharmaceutical Research Company Information
  63. 6.11.2 Sun-Novo Pharmaceutical Research Business Overview
  64. 6.11.3 Sun-Novo Pharmaceutical Research Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sun-Novo Pharmaceutical Research Peptide CRO Services Product Portfolio
  66. 6.11.5 Sun-Novo Pharmaceutical Research Recent Developments
  67. 6.12 Thermo Fisher
  68. 6.12.1 Thermo Fisher Company Information
  69. 6.12.2 Thermo Fisher Business Overview
  70. 6.12.3 Thermo Fisher Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Thermo Fisher Peptide CRO Services Product Portfolio
  72. 6.12.5 Thermo Fisher Recent Developments
  73. 6.13 Syngene
  74. 6.13.1 Syngene Company Information
  75. 6.13.2 Syngene Business Overview
  76. 6.13.3 Syngene Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Syngene Peptide CRO Services Product Portfolio
  78. 6.13.5 Syngene Recent Developments
  79. 6.14 Svar Life Science
  80. 6.14.1 Svar Life Science Company Information
  81. 6.14.2 Svar Life Science Business Overview
  82. 6.14.3 Svar Life Science Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Svar Life Science Peptide CRO Services Product Portfolio
  84. 6.14.5 Svar Life Science Recent Developments
  85. 6.15 PolyPeptide
  86. 6.15.1 PolyPeptide Company Information
  87. 6.15.2 PolyPeptide Business Overview
  88. 6.15.3 PolyPeptide Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 PolyPeptide Peptide CRO Services Product Portfolio
  90. 6.15.5 PolyPeptide Recent Developments
  91. 6.16 PeptiSystems
  92. 6.16.1 PeptiSystems Company Information
  93. 6.16.2 PeptiSystems Business Overview
  94. 6.16.3 PeptiSystems Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 PeptiSystems Peptide CRO Services Product Portfolio
  96. 6.16.5 PeptiSystems Recent Developments
  97. 6.17 Peptide Institute
  98. 6.17.1 Peptide Institute Company Information
  99. 6.17.2 Peptide Institute Business Overview
  100. 6.17.3 Peptide Institute Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Peptide Institute Peptide CRO Services Product Portfolio
  102. 6.17.5 Peptide Institute Recent Developments
  103. 6.18 Immunocure
  104. 6.18.1 Immunocure Company Information
  105. 6.18.2 Immunocure Business Overview
  106. 6.18.3 Immunocure Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Immunocure Peptide CRO Services Product Portfolio
  108. 6.18.5 Immunocure Recent Developments
  109. 6.19 Cusabio
  110. 6.19.1 Cusabio Company Information
  111. 6.19.2 Cusabio Business Overview
  112. 6.19.3 Cusabio Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Cusabio Peptide CRO Services Product Portfolio
  114. 6.19.5 Cusabio Recent Developments
  115. 6.20 CSBio
  116. 6.20.1 CSBio Company Information
  117. 6.20.2 CSBio Business Overview
  118. 6.20.3 CSBio Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 CSBio Peptide CRO Services Product Portfolio
  120. 6.20.5 CSBio Recent Developments
  121. 6.21 CPC Scientific
  122. 6.21.1 CPC Scientific Company Information
  123. 6.21.2 CPC Scientific Business Overview
  124. 6.21.3 CPC Scientific Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 CPC Scientific Peptide CRO Services Product Portfolio
  126. 6.21.5 CPC Scientific Recent Developments
  127. 6.22 Buchi
  128. 6.22.1 Buchi Company Information
  129. 6.22.2 Buchi Business Overview
  130. 6.22.3 Buchi Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Buchi Peptide CRO Services Product Portfolio
  132. 6.22.5 Buchi Recent Developments
  133. 6.23 Bachem AG
  134. 6.23.1 Bachem AG Company Information
  135. 6.23.2 Bachem AG Business Overview
  136. 6.23.3 Bachem AG Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Bachem AG Peptide CRO Services Product Portfolio
  138. 6.23.5 Bachem AG Recent Developments
  139. 6.24 Aurigene Pharmaceutical Services
  140. 6.24.1 Aurigene Pharmaceutical Services Company Information
  141. 6.24.2 Aurigene Pharmaceutical Services Business Overview
  142. 6.24.3 Aurigene Pharmaceutical Services Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Aurigene Pharmaceutical Services Peptide CRO Services Product Portfolio
  144. 6.24.5 Aurigene Pharmaceutical Services Recent Developments
  145. 6.25 AmbioPharm
  146. 6.25.1 AmbioPharm Company Information
  147. 6.25.2 AmbioPharm Business Overview
  148. 6.25.3 AmbioPharm Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 AmbioPharm Peptide CRO Services Product Portfolio
  150. 6.25.5 AmbioPharm Recent Developments
  151. 6.26 ABZENA PLC
  152. 6.26.1 ABZENA PLC Company Information
  153. 6.26.2 ABZENA PLC Business Overview
  154. 6.26.3 ABZENA PLC Peptide CRO Services Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 ABZENA PLC Peptide CRO Services Product Portfolio
  156. 6.26.5 ABZENA PLC Recent Developments
7 North America
  1. 7.1 North America Peptide CRO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Peptide CRO Services Market Size by Country (2021-2026)
  3. 7.3 North America Peptide CRO Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Peptide CRO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Peptide CRO Services Market Size by Country (2021-2026)
  3. 8.3 Europe Peptide CRO Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Peptide CRO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Peptide CRO Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Peptide CRO Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Peptide CRO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Peptide CRO Services Market Size by Country (2021-2026)
  3. 10.3 South America Peptide CRO Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Peptide CRO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Peptide CRO Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Peptide CRO Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst